Discovery of Zilucoplan: A Peptide Complement C5 Inhibitor in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
Time: 4:00 pm
day: Conference Day 1
Details:
• Brief introduction of UCB and origin of zilucoplan
• Examining the biology background and early discovery of zilucoplan – a small, subcutaneously administered, macrocyclic peptide
• Discussing lessons learnt from this clinical success and future directions
